Arvaya HealthcareBOM:524723 34 EBITDA Margin % is 29.47% as of Mar. 2026. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹48.97 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 117 Medical Distribution companies, Arvaya Healthcare ranks better than 95.73% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Arvaya Healthcare's EBITDA for the
three
months ended in Mar. 2026 was ₹26.85 Mil. Arvaya Healthcare's Revenue for the
three
months ended in Mar. 2026 was ₹91.13 Mil. Therefore, Arvaya Healthcare's EBITDA margin for the quarter that ended in Mar. 2026 was 29.47%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Arvaya Healthcare EBITDA Margin % Related Terms
Arvaya Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, CAH, COR: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a EBITDA Margin % of 29.47% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #5 out of 117 companies in the Medical Distribution industry, placing it in the top 4.3%.
Is Arvaya Healthcare's EBITDA Margin % too high?
Arvaya Healthcare's current EBITDA Margin % is 29.47%. The Medical Distribution industry median EBITDA Margin % is 4.28. Arvaya Healthcare's value of 29.47% is 588.6% above this industry median. Based on the distribution chart, Arvaya Healthcare ranks #5 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's EBITDA Margin % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #5 out of 117 companies for EBITDA Margin %. This places Arvaya Healthcare in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 4.28. Arvaya Healthcare's value of 29.47% is 588.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.28, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current EBITDA Margin % of 29.47% is 588.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current EBITDA Margin % is 29.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹48.97, compared to a current price of ₹67.11 — trading 37% above its estimated fair value. The current EBITDA Margin % is 29.47% and 588.6% above the Medical Distribution industry median of 4.28. Arvaya Healthcare's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current EBITDA Margin % is 29.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹67.11 is trading 37% above its estimated GF Value™ of ₹48.97.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
EBITDA Margin %: 29.47%
GF Value™: ₹48.97 vs. price of ₹67.11 (37% above fair value)
Industry Position: 588.6% above the Medical Distribution median (#5 of 117)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score
Get the complete analysis for BOM:524723
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
